A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab

Update Il y a 5 ans
Reference: NCT01285466

Woman and Man

Extract

The purpose of the trial is to determine the maximum tolerated dose (MTD) of BEZ235 and BKM120 in combination with weekly paclitaxel and weekly paclitaxel/trastuzumab.


Inclusion criteria

  • Metastatic or Locally Advanced Solid Tumors,


Links